A pan-cancer analysis of copper homeostasis-related gene lipoyltransferase 1: Its potential biological functions and prognosis values

被引:18
|
作者
Liu, Ying [1 ]
Luo, Gengqiu [2 ,3 ]
Yan, Yuanliang [4 ]
Peng, Jinwu [2 ,3 ]
机构
[1] Xiangya Changde Hosp, Dept Pathol, Changde, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Basic Sch Med, Dept Pathol, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Peoples R China
基金
中国国家自然科学基金;
关键词
LIPT1; pan-cancer; biological functions; prognosis; immune; LIPOYLATION DEFECT; CELL-DEATH; MUTATIONS;
D O I
10.3389/fgene.2022.1038174
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
As a key copper homeostasis-related molecule, lipoyltransferase 1 (LIPT1) is an essential enzyme for the activation of mitochondrial 2-ketoacid dehydrogenase, participating in fatty acylation. However, the biological significances of LIPT1 in the pan-cancer are unclear. Here, we comprehensively analyzed the functional characteristics of LIPT1 in human cancers and its roles in immune response. We found that LIPT1 was down-regulated in some cancers. And LIPT1 overexpression is associated with favorable prognosis in these patients, such as breast cancer, clear cell renal cell carcinoma, ovarian cancer and gastric cancer. We also explored the mutational status and methylation levels of LIPT1 in human cancers. Gene enrichment analysis indicated that abnormally expressed LIPT1 was significantly associated with immune cells infiltration, such as B cells, CD8(+) T cells and cancer-associated fibroblast cells. The result from single cell sequencing reflected the important roles of LIPT1 in the regulation of several biological behaviors of cancer cells, such as DNA damage response and cell apoptosis. Taken together, our research could provide a comprehensive overview about the significances of LIPT1 in human pan-cancer progression, prognosis and immune.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Pan-Cancer Analysis of ART1 and its Potential Value in Gastric Cancer
    Wu, Zhiping
    Song, Siyuan
    Zhou, Jiayu
    Zhang, Qiling
    Yu, Jiangyi
    JOURNAL OF CANCER, 2024, 15 (12): : 3684 - 3707
  • [22] YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
    Hu, Jian
    Qiu, Dongxu
    Yu, Anze
    Hu, Jiao
    Deng, Hao
    Li, Huihuang
    Yi, Zhenglin
    Chen, Jinbo
    Zu, Xiongbing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD
    Lin, Jiahui
    Wang, Guowei
    Cheng, Sha
    Hu, Yanan
    Li, Huan
    Feng, Wanjiang
    Liu, Xiaoming
    Xu, Canxia
    MEDIATORS OF INFLAMMATION, 2023, 2023
  • [24] Pan-cancer analysis of fusion gene druggability and neoantigen potential
    Edgren, Henrik
    Ruusulehto, Anja
    Ojala, Kalle
    Laaksonen, Maria
    CANCER RESEARCH, 2016, 76
  • [25] A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma
    Ma, Ning
    Zhou, Tian
    Li, Chunyu
    Luo, Xue
    Chen, Song
    Zhu, Xue-yin
    Chen, Xing-hong
    Liu, Haoxi
    Tian, Hai-ying
    Gao, Qing -jun
    Zhao, Dai-wei
    HELIYON, 2024, 10 (03)
  • [26] Pan-cancer analysis reveals copper transporters as promising potential targets
    Li, Yueqin
    Yu, Zhen
    HELIYON, 2024, 10 (17)
  • [27] Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
    Zheng, Haosheng
    Long, Guojie
    Zheng, Yuzhen
    Yang, Xingping
    Cai, Weijie
    He, Shiyun
    Qin, Xianyu
    Liao, Hongying
    CANCERS, 2022, 14 (21)
  • [28] Pan-cancer analysis verifies COLGALT1 as a potential target for immunotherapy and survival prognosis
    Wang, Fengyan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 49 - 49
  • [29] Pan-cancer analysis verifies COLGALT1 as a potential target for immunotherapy and survival prognosis
    Wang, Fengyan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 49 - 49
  • [30] EXO1 as a potential biomarker for prognosis, immune infiltration, and immunotherapy in pan-cancer analysis
    Jikang Wang
    Fubo Wang
    Haoxuan Huang
    Functional & Integrative Genomics, 2025, 25 (1)